There are several factors taken into consideration when testing for breast cancer recurrence as explained by Dr. Harness in this video. Find out how new technology allows doctors to better determine the chance of cancer recurring within a 10 year period and how receptive it will be to treatment.
The ideal time to use neoadjuvant therapy is explained by Dr. Harness as when a cancer is very large or HER-2/neu positive. Since each therapy has advantages and disadvantages it is not a question of which therapy is better than the other but which is the right therapy for the situation. [...]
Find out how Proton Beam Therapy uses proton as external beam therapy, with the dosage falling off rapidly afterwards. Dr. Forouzannia explains that this therapy is still considered experimental. Afshin Forouzannia, MD: Proton Beam Therapy is a form of external beam therapy, but instead of using photon rays like standard external beam [...]
Find out how two genes, BRCA 1 and BRCA 2, can cause cancer to develop more commonly in the breast and the ovary. Family history, age of patient, and number of relatives that had those cancers are factors in breast cancer risk assessment. David A Margileth, MD: Prior to our knowing [...]
In this video, find out how genetic counselors and gene testing help patients determine breast and ovarian cancer risk through blood testing. Dr. David A. Margileth: Our approach is to have the patient see a genetics counselor that will make a three generation family tree, get all the information they can about the incidents [...]
In this video, Dr. Margileth reassures patients that despite the fears of many women facing chemotherapy treatment, there is no feeling or pain associated when the chemotherapy is delivered. Dr. David A. Margileth, MD: The delivery of the chemotherapy, I think, is something that many women either fear or have no clue about. [...]
In this video, Dr. Margileth explains what research has shown in improving neoadjuvant and adjuvant therapies, including the drugs Herceptin, Pertuzamab, Maytansine, and Afinitor. Dr. David A. Margileth, MD: The research in breast cancer in neoadjuvant and adjuvant therapies revolves around several different components. Obviously, we are trying to combine known drugs in different ways, [...]
In this video, Dr. Margileth explains that Adjuvant and Neoadjuvant chemotherapies are two major groups of toxicity: one are the problems that occur during the chemotherapy, or acute toxicities; and the other is late toxicities, that is, those toxicities after the chemotherapy has been completed. Dr. David A. Margileth, MD: I like to tell my [...]
In this video, Dr. Jay Harness explains that he is just one of the members of a multidisciplinary team that ensures treatment is tailored to the individual needs in the treatment of breast cancer. Dr. Jay Harness, MD, FACS: I am always talking on this side about a multidisciplinary team of experts. Well are these [...]
In this video, Dr. Harness explains that genetic tests look at an individual’s inherited traits or genes by looking at groups of genes and how active they are. A genomic test, such as the Oncotype DX Test, provides information about the tumor. Dr. Jay K. Harness, MD, FACS: Genetic tests look at an individual’s inherited [...]
